Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
+0.18% | +1.27% |
01:14pm | Sanofi: positive phase 1/2 data in leukemia | CF |
07:00am | Innate Pharma and Sanofi Shares Updated Results from the Sanofi Developed Blood Cancer Phase 1/2 1/2 SAR443579/IPH6101 Trial | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- SAN Stock
- GCVRZ Stock
- Revisions Sanofi